Propiedad y actividad de insiders de Genelux Corporation (GNLX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $2.34 |
| Capitalización | $105M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-31 | Cappello Joseph | S-Sale | 10,257 | $28K |
| 2026-08-31 | Zindrick Thomas | S-Sale | 34,463 | $92K |
| 2026-08-31 | Yu Yong | S-Sale | 9,683 | $27K |
| 2026-08-04 | Yu Yong | S-Sale | 653 | $2K |
| 2026-08-04 | Cappello Joseph | S-Sale | 653 | $2K |
| 2026-08-04 | Zindrick Thomas | S-Sale | 3,023 | $9K |
| 2026-07-01 | Smither John W | S-Sale | 12,000 | $35K |
| 2026-06-16 | Pulisic Matthew | A-Award | 278,906 | |
| 2026-06-16 | Groen Eric | A-Award | 233,957 | |
| 2026-06-16 | Cappello Joseph | A-Award | 174,841 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $425000 | $11.3M | $4.5M | $397000 | $9.4M | $8.6M | $5.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $13.8M | $22.3M | $9.3M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $551000 | $11.5M | $5.8M | $1.9M | $24.2M | $31.5M | $15.1M |
| Inmovilizado Material | $2.6M | $2.5M | $2.2M | $2.0M | $3.6M | $3.1M | $3.8M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $3.3M | $14.0M | $8.1M | $5.5M | $27.9M | $34.7M | $19.0M |
| Cuentas por Pagar | 0 | $927000 | $4.5M | $6.8M | $3.8M | $5.6M | $4.4M |
| Deuda a Corto | $4.6M | $3.6M | $6.2M | $16.4M | 0 | $329000 | 0 |
| Pasivos Corrientes | $14.7M | $14.5M | $22.5M | $31.6M | $6.6M | $6.9M | $6.2M |
| Deuda a Largo | $13.0M | $21.7M | $18.0M | $8.5M | 0 | 0 | 0 |
| Pasivos Totales | $28.1M | $36.7M | $41.2M | $41.3M | $8.4M | $8.4M | $7.5M |
| Reservas | -$154.6M | -$168.2M | -$184.6M | -$189.8M | -$221.5M | -$251.4M | -$283.5M |
| Patrimonio Neto | -$24.8M | -$22.7M | -$33.1M | -$35.8M | $19.5M | $26.3M | $11.5M |
| Deuda Total | $18.0M | $26.1M | $25.3M | $26.4M | $2.5M | $1.9M | $1.7M |
| Deuda Neta | $17.5M | $14.7M | $20.8M | $26.0M | -$20.7M | -$29.0M | -$12.9M |
| Capital Circulante | -$14.2M | -$3.0M | -$16.7M | -$29.7M | $17.6M | $24.6M | $8.9M |
Salud financiera
| Deuda / Patrimonio | 0.15 |
| Ratio corriente | 2.39 |
Rentabilidad
| Rentabilidad sobre capital | -195.42% |
| Rentabilidad sobre capital invertido | -192.18% |
| Rentabilidad sobre activos | -128.96% |
| Margen bruto | -1762.50% |
| Margen operativo | -445200.00% |
| Margen neto | -422412.50% |
Empresas relacionadas: ACIU · ALDX · CADL · CLLS · CTNM · DRTS · LXEO
Explorar sector: Healthcare · Biotechnology
Más secciones de GNLX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones